FAQs

GLP-1 semaglutide and GLP-1/GIP tirzepatide are the main medications we prescribe for medical weight management. Your provider will determine which treatment is appropriate based on your individual health history and treatment goals. 

Weight loss varies from person to person and depends on the medication, dose, treatment duration, health history, and other individual factors. Clinical trials of FDA-approved weight management medications have shown significant weight loss, but individual results will vary. Your health care provider can discuss realistic expectations based on your treatment plan. 

Please fill out the contact us form to ask for the most up-to-date pricing. We may also price match local clinics; please ask us!  

Yes.  Contact TSA for any special requirements for flight travel.

 It works to promote weight loss by reducing appetite, increasing feelings of fullness, and slowing down stomach emptying, this can lead to a decrease in calorie intake.

Yes.  You will be significantly less hungry, but we can advise each patient on the proper nutrition.

We work with private financing options to help make medical weight management more accessible. Contact us to learn more about available payment options. 

The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment such as high blood pressure, Type 2 diabetes or high cholesterol or in patients with a BMI of 30 kg/m2 or greater.    

Those with a personal or family history of medullary thyroid carcinoma (MTC)  Multiple Endocrine Neoplasia syndrome type 2 , prior serious hypersensitivity reaction to semaglutide or pancreatitis, may be disqualified from taking the medication.

Coverage and eligibility for HSA, FSA, or other health savings accounts can vary by plan. Please check with your plan administrator to confirm whether your treatment and related expenses are eligible.